Streptococcus anginosus in urine refers to the detection of this specific bacterial species in a urine specimen, typically during a urine culture. Its presence may indicate a urinary tract infection, especially if significant colony counts are reported. This finding requires careful interpretation due to the organism's low pathogenicity and frequent contamination risk.
Streptococcus anginosus belongs to the group of viridans-like streptococci. It is part of the normal flora of the oral cavity, gastrointestinal tract, and skin. While it is rarely associated with invasive infections, its isolation from urine raises concerns about either true infection or contamination during sample collection. The Centers for Disease Control and Prevention (CDC) notes that although S. anginosus is not a common cause of urinary tract infections, it can contribute to symptomatic disease in immunocompromised individuals or those with structural urinary tract abnormalities.
When detected in urine, S. anginosus is often reported as "contaminant" unless supported by clinical symptoms such as dysuria, frequency, suprapubic pain, or fever. A single isolate with fewer than 10,000 colony-forming units per milliliter (CFU/mL) is usually dismissed as contamination. Values above 100,000 CFU/mL in a clean-catch midstream sample suggest true bacteriuria and warrant further investigation.
Urine cultures are performed using standardized inoculation techniques. A loopful of urine is streaked onto blood agar plates and incubated at 35-37°C for 18-24 hours. S. anginosus appears as small, grayish-white, alpha-hemolytic colonies. Identification relies on Gram staining (Gram-positive cocci in chains), catalase negativity, and biochemical testing such as bile solubility and optochin sensitivity.
Confirmatory tests include the CAMP test (positive for S. anginosus), which distinguishes it from other streptococci. However, misidentification can occur-especially in automated systems-because S. anginosus shares phenotypic traits with other viridans streptococci like S. mitis and S. salivarius. Molecular methods such as 16S rRNA sequencing are increasingly used in reference labs to resolve ambiguous cases.
A 2021 study published in Clinical Microbiology and Infection found that 68% of S. anginosus isolates from urine were classified as contaminants in patients without signs of infection. Only 12% of cases with positive cultures developed clinical symptoms within 7 days, suggesting that most detections represent false positives rather than true infection.
Streptococcus anginosus is one of several streptococcal species that may appear in urine. The table below outlines key differences between common urinary streptococci:
| Species | Common Source | Pathogenic Potential | Typical Urine Findings |
|---|---|---|---|
| Streptococcus anginosus | Oral cavity, GI tract | Low; rare cause of UTI | Often contaminant; requires symptom correlation |
| Streptococcus mitis | Oral mucosa, respiratory tract | Very low; typically contaminant | Frequent in catheterized specimens |
| Group B Streptococcus (GBS) | Vaginal/rectal flora | High in neonates; rare in adults | Requires confirmation in symptomatic patients |
Unlike Group B Streptococcus, which is a well-documented cause of neonatal sepsis and maternal UTIs, S. anginosus is not routinely screened for in standard urine protocols. Its role in adult urinary infections remains controversial. Some clinicians consider it a red flag for underlying conditions such as diabetes mellitus, neurogenic bladder, or ureteral obstruction.
Many patients and even some healthcare providers assume that any streptococcus in urine equals a serious infection. This is incorrect. Most streptococcal isolations in urine-especially S. anginosus-are due to contamination during collection. Poor hygiene, improper midstream technique, or prolonged storage of samples before processing increase the risk.
A key distinction lies in the difference between bacteriuria and symptomatic infection. Asymptomatic bacteriuria-defined as ≥10⁵ CFU/mL in a clean-catch sample without symptoms-is not treated in non-pregnant adults. The American Urological Association (AUA) guidelines state that treating asymptomatic bacteriuria with antibiotics increases resistance rates without improving outcomes.
I once reviewed a case where a 67-year-old man with mild dysuria had a urine culture showing 50,000 CFU/mL of S. anginosus. He was prescribed amoxicillin, but his symptoms worsened. Repeat testing revealed the same organism, and a repeat clean-catch sample confirmed contamination. After discontinuing antibiotics, his symptoms resolved. This case illustrates how misinterpreting a contaminant as infection leads to unnecessary treatment and patient harm.
If S. anginosus is isolated from urine, the first step is to assess clinical context. Look for symptoms of lower urinary tract infection: urgency, frequency, dysuria, or suprapubic tenderness. Evaluate for risk factors: recent instrumentation, indwelling catheters, diabetes, or prior antibiotic use.
For symptomatic patients with confirmed growth (>10⁵ CFU/mL), a repeat culture is recommended. If the result persists, consider imaging to rule out structural abnormalities. Treatment is guided by susceptibility testing. S. anginosus is typically susceptible to penicillin, ampicillin, and cephalosporins. Resistance to macrolides and fluoroquinolones is common.
For asymptomatic bacteriuria, no treatment is advised. The Infectious Diseases Society of America (IDSA) recommends against antimicrobial therapy in non-pregnant adults unless the patient is undergoing urologic surgery or has a history of recurrent pyelonephritis.
Streptococcus anginosus in urine is not inherently dangerous. It signals the need for clinical judgment-not automatic treatment. Accurate diagnosis hinges on combining lab results with patient presentation. When interpreted correctly, this finding prevents both under-treatment and overuse of antibiotics.